Well, so far, thats the second director to aquire more. Who cares how much it’s worth. 2-0 to the buying side.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025